US Stock MarketDetailed Quotes

PHAT Phathom Pharmaceuticals

Watchlist
  • 11.750
  • +0.940+8.70%
Close Aug 8 16:00 ET
  • 11.740
  • -0.010-0.09%
Post 16:50 ET
687.79MMarket Cap-2268P/E (TTM)

Phathom Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Phathom Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 8, 2024

Revenue(YoY)

7.32M

0.00%
EPS(YoY)

-1.56

-85.71%
Analyst Rating

Strong Buy

Aug 8, 2024

Phathom Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 22.136M--
--2024/Q3-- / 11.125M--
Aug 8, 20242024/Q27.324M / 5.711M--
May 9, 20242024/Q11.912M / 2.141M--
Mar 7, 20242023/Q4682.000K / 379.200K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 22.136M--
--2024/Q3-- / 11.125M--
Aug 8, 20242024/Q27.324M / 5.711M--
May 9, 20242024/Q11.912M / 2.141M--
Mar 7, 20242023/Q4682.000K / 379.200K--

Unlock Free Earnings Estimates

Phathom Pharmaceuticals Earnings Reports

  • Phathom Pharmaceuticals | 10-Q: Quarterly report

    16:53 ET

  • Phathom Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Jun 14 16:11 ET

  • Phathom Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Jun 14 16:11 ET

  • Phathom Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 8, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg